RxDoctor Payments Data

William Perkins

Gastroenterology · Sumter, SCNPI 1871813733

Payments from drug & device makers

$2,357in general payments, 2019–2025

Across 114 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$429
  • Ambu Inc.$180
  • Boston Scientific$105
  • Amgen$102
  • Johnson & Johnson$77
  • plus $450 from 14 others

What the payments were for

  • Food & beverage$2,29297%
  • Education$653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,357 in reported general payments places this provider in the 40th percentile of 259 gastroenterology providers in South Carolina.

See all gastroenterology providers in South Carolina

Medicare billing

Part B allowed, 2024
$42,973
Medicare patients
156
Services billed
322

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide30$19,206
Azathioprine12$1,690
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates14$905
CholestyramineCholestyramine (With Sugar)12$893
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl36$636
Dicyclomine Hcl27$574
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl31$569
Pantoprazole Sodium27$397
Omeprazole46$379
Rabeprazole Sodium11$291
Esomeprazole Magnesium15$191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,015$19,20630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 259 gastroenterology providers in South Carolina.

Other gastroenterology in Sumter

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →